National cancer genetic screening program at Emory offers at-home testing

JScreen, a national at-home genetic screening program based at Emory’s Department of Human Genetics in partnership with Winship, has announced a new program that offers at-home testing for more than 60 cancer susceptibility genes associated with hereditary risks for breast, ovarian, prostate, colorectal, skin, and other cancers. Karen Arnovitz Grinzaid, MS, CGC, JScreen's executive director, and Jane Lowe Meisel, MD, medical director for JScreen’s cancer program, are both Winship members.

McCullough receives R01 for breast cancer disparities research

Lauren E. McCullough, PhD, MSPH has received an R01 grant from the National Cancer Institute to examine multi-level drivers of both breast recurrence and mortality among women in Georgia. The project aims to identify modifiable targets to facilitate the prioritization of interventions.

View in NIH RePORTER

New robot helps diagnose and treat lung cancers earlier

Physicians at Winship at Emory Saint Joseph's Hospital will be the first in Georgia to use a new state-of-the-art Ion robot to diagnose lung cancers earlier and less invasively. Pictured: Drs. Manu Sancheti and Alejandro Sardi inside the hybrid operating room at Emory Saint Joseph's Hospital.

Call for abstracts: NCI Lung Cancer SPORE workshop

Winship investigators are invited to submit abstracts for oral and poster presentation at the 2021 National Cancer Institute Lung Cancer SPORE Workshop, a Winship-hosted virtual event taking place June 16-18. Abstracts are due April 16.

Winship team members appointed to Beryl Institute council

Davida Lee-Williams, director of guest and volunteer services, and Arielle Brown, volunteer services coordinator, have joined the Volunteer Professionals Council of the Beryl Institute, dedicated to advancing the human experience in health care.

Learn More

Winship to hold virtual "Fashion a Cure" event

The Friends of Winship Fashion a Cure Fashion Show, which supports Winship research focused on cancers affecting women, will hold a virtual event on April 13. The program will include remarks from Kevin Kalinsky, MD, MS, director of Winship’s Glenn Family Breast Center.

Emory’s Move More Challenge kicks off March 22

For the sixth year, Emory employees are invited to participate in Move More, a physical activity challenge that offers an opportunity for fun competition and teamwork among coworkers while tracking steps. The six-week competition begins on March 22.

What's new | Emory Integrated Genomics Shared Resource

The Emory Integrated Genomics Core, one of Winship’s 11 shared resources offering advanced research technologies and services, provides leading-edge genomics platforms and expertise. The SageELF, an electrophoresis system and one of the core's newer platforms, captures DNA and protein samples into 12 contiguous fractions within 2-3 hours. Contact Emory Integrated Genomics (eigc@emory.edu) to learn more about this and other technologies and services to support your research.

Learn More

Below are four selected Winship publications out of 35 published over the past week:

Owonikoko TK, Park K, Govindan R, Ready N, Reck M, Peters S, Dakhil SR, Navarro A, Rodríguez-Cid J, Schenker M, Lee JS, Gutierrez V, Percent I, Morgensztern D, Barrios CH, Greillier L, Baka S, Patel M, Lin WH, Selvaggi G, Baudelet C, Baden J, Pandya D, Doshi P, Kim HR. Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451. Journal of Clinical Oncology: official journal of the American Society of Clinical Oncology. 2021:JCO2002212. PubMed PMID: 33683919.

View in PubMed

Troeschel AN, Hartman TJ, Flanders WD, Akinyemiju T, Judd S, Bostick RM. A novel evolutionary-concordance lifestyle score is inversely associated with all-cause, all-cancer, and all-cardiovascular disease mortality risk. European Journal of Nutrition. 2021; PubMed PMID: 33675389.

View in PubMed

Sun Y, Anyalebechi JC, Sun H, Yumoto T, Xue M, Liu D, Liang Z, Coopersmith CM, Ford ML. Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts. JCI Insight. 2021; 6(5). PubMed PMID: 33682797.

View in PubMed

Mato AR, Shah NN, Jurczak W, Cheah CY, Pagel JM, Woyach JA, Fakhri B, Eyre TA, Lamanna N, Patel MR, Alencar A, Lech-Maranda E, Wierda WG, Coombs CC, Gerson JN, Ghia P, Le Gouill S, Lewis DJ, Sundaram S, Cohen JB, Flinn IW, Tam CS, Barve MA, Kuss B, Taylor J, Abdel-Wahab O, Schuster SJ, Palomba ML, Lewis KL, Roeker LE, Davids MS, Tan XN, Fenske TS, Wallin J, Tsai DE, Ku NC, Zhu E, Chen J, Yin M, Nair B, Ebata K, Marella N, Brown JR, Wang M. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study. Lancet (London, England). 2021; 397(10277):892-901. PubMed PMID: 33676628.

View in PubMed